Search Browse Earnings

Phathom Pharmaceuticals, Inc. — SlamSEC

Phathom Pharmaceuticals, Inc.

Nasdaq:PHAT

Pharmaceutical Preparations·FLORHAM PARK, NJ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$55.3M

+8001.5% YoY

FY 2025

Adj. EBITDA

-$276.7M

-500.7% margin

FY 2025

Net Income

-$334.3M

-605.1% margin

FY 2025

EPS (Diluted)

-$5.29

FY 2025

Stock Price

$10.37

-6.7%

2026-03-12

52W Range

$2.21 – $18.31

P/E Ratio

-2.0x

Market Cap

$817.1M

Cash

$297.3M

FY 2025

Total Debt

$201.4M

FY 2025

Net Cash

$95.9M

FY 2025

Enterprise Value

$721.3M

Debt / EBITDA

0.3x

FY 2025

EV / EBITDA

-2.6x

Employees

—